-
1
-
-
50549121134
-
The distribution of secondary growths in cancer of the breast
-
Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889, 1:571-573.
-
(1889)
Lancet
, vol.1
, pp. 571-573
-
-
Paget, S.1
-
2
-
-
0035499267
-
Stem cells, cancer, and cancer stem cells
-
10.1038/35102167, 11689955
-
Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111. 10.1038/35102167, 11689955.
-
(2001)
Nature
, vol.414
, pp. 105-111
-
-
Reya, T.1
Morrison, S.J.2
Clarke, M.F.3
Weissman, I.L.4
-
3
-
-
0037388204
-
Prospective identification of tumorigenic breast cancer cells
-
10.1073/pnas.0530291100, 153034, 12629218
-
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 2003, 100:3983-3988. 10.1073/pnas.0530291100, 153034, 12629218.
-
(2003)
Proc. Natl Acad. Sci. USA
, vol.100
, pp. 3983-3988
-
-
Al-Hajj, M.1
Wicha, M.S.2
Benito-Hernandez, A.3
Morrison, S.J.4
Clarke, M.F.5
-
4
-
-
74949129868
-
Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer
-
10.1158/1078-0432.CCR-09-1630, 2874875, 20028757
-
Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, Houvenaeghel G, Extra JM, Bertucci F, Jacquemier J, Xerri L, Dontu G, Stassi G, Xiao Y, Barsky SH, Birnbaum D, Viens P, Wicha MS. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 2010, 16:45-55. 10.1158/1078-0432.CCR-09-1630, 2874875, 20028757.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 45-55
-
-
Charafe-Jauffret, E.1
Ginestier, C.2
Iovino, F.3
Tarpin, C.4
Diebel, M.5
Esterni, B.6
Houvenaeghel, G.7
Extra, J.M.8
Bertucci, F.9
Jacquemier, J.10
Xerri, L.11
Dontu, G.12
Stassi, G.13
Xiao, Y.14
Barsky, S.H.15
Birnbaum, D.16
Viens, P.17
Wicha, M.S.18
-
5
-
-
58149340463
-
Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme
-
10.1158/1078-0432.CCR-08-0644, 19088037
-
Pallini R, Ricci-Vitiani L, Banna GL, Signore M, Lombardi D, Todaro M, Stassi G, Martini M, Maira G, Larocca LM, De Maria R. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res 2008, 14:8205-8212. 10.1158/1078-0432.CCR-08-0644, 19088037.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 8205-8212
-
-
Pallini, R.1
Ricci-Vitiani, L.2
Banna, G.L.3
Signore, M.4
Lombardi, D.5
Todaro, M.6
Stassi, G.7
Martini, M.8
Maira, G.9
Larocca, L.M.10
De Maria, R.11
-
6
-
-
40749155451
-
Stem cell marker CD133 affects clinical outcome in glioma patients
-
10.1158/1078-0432.CCR-07-0932, 18172261
-
Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende CC. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 2008, 14:123-129. 10.1158/1078-0432.CCR-07-0932, 18172261.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 123-129
-
-
Zeppernick, F.1
Ahmadi, R.2
Campos, B.3
Dictus, C.4
Helmke, B.M.5
Becker, N.6
Lichter, P.7
Unterberg, A.8
Radlwimmer, B.9
Herold-Mende, C.C.10
-
7
-
-
0344735881
-
Cancerous stem cells can arise from pediatric brain tumors
-
10.1073/pnas.2036535100, 299944, 14645703
-
Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, Kornblum HI. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 2003, 100:15178-15183. 10.1073/pnas.2036535100, 299944, 14645703.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 15178-15183
-
-
Hemmati, H.D.1
Nakano, I.2
Lazareff, J.A.3
Masterman-Smith, M.4
Geschwind, D.H.5
Bronner-Fraser, M.6
Kornblum, H.I.7
-
8
-
-
38349165576
-
Identification of cells initiating human melanomas
-
10.1038/nature06489, 3660705, 18202660
-
Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C, Fuhlbrigge RC, Kupper TS, Sayegh MH, Frank MH. Identification of cells initiating human melanomas. Nature 2008, 451:345-349. 10.1038/nature06489, 3660705, 18202660.
-
(2008)
Nature
, vol.451
, pp. 345-349
-
-
Schatton, T.1
Murphy, G.F.2
Frank, N.Y.3
Yamaura, K.4
Waaga-Gasser, A.M.5
Gasser, M.6
Zhan, Q.7
Jordan, S.8
Duncan, L.M.9
Weishaupt, C.10
Fuhlbrigge, R.C.11
Kupper, T.S.12
Sayegh, M.H.13
Frank, M.H.14
-
9
-
-
0141842674
-
Identification of a cancer stem cell in human brain tumors
-
Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-5828.
-
(2003)
Cancer Res
, vol.63
, pp. 5821-5828
-
-
Singh, S.K.1
Clarke, I.D.2
Terasaki, M.3
Bonn, V.E.4
Hawkins, C.5
Squire, J.6
Dirks, P.B.7
-
10
-
-
9244241576
-
Identification of human brain tumour initiating cells
-
10.1038/nature03128, 15549107
-
Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401. 10.1038/nature03128, 15549107.
-
(2004)
Nature
, vol.432
, pp. 396-401
-
-
Singh, S.K.1
Hawkins, C.2
Clarke, I.D.3
Squire, J.A.4
Bayani, J.5
Hide, T.6
Henkelman, R.M.7
Cusimano, M.D.8
Dirks, P.B.9
-
11
-
-
84864854371
-
Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas
-
10.1126/science.1224676, 22855427
-
Schepers AG, Snippert HJ, Stange DE, van den Born M, van Es JH, van de Wetering M, Clevers H. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 2012, 337:730-735. 10.1126/science.1224676, 22855427.
-
(2012)
Science
, vol.337
, pp. 730-735
-
-
Schepers, A.G.1
Snippert, H.J.2
Stange, D.E.3
van den Born, M.4
van Es, J.H.5
van de Wetering, M.6
Clevers, H.7
-
12
-
-
84865203983
-
A restricted cell population propagates glioblastoma growth after chemotherapy
-
#3427400, 10.1038/nature11287, 3427400, 22854781
-
Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, Parada LF. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012, 488:522-526. #3427400, 10.1038/nature11287, 3427400, 22854781.
-
(2012)
Nature
, vol.488
, pp. 522-526
-
-
Chen, J.1
Li, Y.2
Yu, T.S.3
McKay, R.M.4
Burns, D.K.5
Kernie, S.G.6
Parada, L.F.7
-
13
-
-
84865222310
-
Defining the mode of tumour growth by clonal analysis
-
10.1038/nature11344, 22854777
-
Driessens G, Beck B, Caauwe A, Simons BD, Blanpain C. Defining the mode of tumour growth by clonal analysis. Nature 2012, 488:527-530. 10.1038/nature11344, 22854777.
-
(2012)
Nature
, vol.488
, pp. 527-530
-
-
Driessens, G.1
Beck, B.2
Caauwe, A.3
Simons, B.D.4
Blanpain, C.5
-
14
-
-
33845317573
-
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
-
10.1038/nature05236, 17051156
-
Bao S. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760. 10.1038/nature05236, 17051156.
-
(2006)
Nature
, vol.444
, pp. 756-760
-
-
Bao, S.1
-
15
-
-
33745198882
-
Chemotherapy resistance of glioblastoma stem cells
-
10.1038/sj.cdd.4401872, 16456578
-
Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G, Pilozzi E, Larocca LM, Peschle C, De Maria R. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 2006, 13:1238-1241. 10.1038/sj.cdd.4401872, 16456578.
-
(2006)
Cell Death Differ
, vol.13
, pp. 1238-1241
-
-
Eramo, A.1
Ricci-Vitiani, L.2
Zeuner, A.3
Pallini, R.4
Lotti, F.5
Sette, G.6
Pilozzi, E.7
Larocca, L.M.8
Peschle, C.9
De Maria, R.10
-
16
-
-
77956034139
-
Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment
-
10.1186/bcr2479, 2880434, 20158881
-
Lagadec C, Vlashi E, Della Donna L, Meng Y, Dekmezian C, Kim K, Pajonk F. Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Res 2010, 12:R13. 10.1186/bcr2479, 2880434, 20158881.
-
(2010)
Breast Cancer Res
, vol.12
-
-
Lagadec, C.1
Vlashi, E.2
Della Donna, L.3
Meng, Y.4
Dekmezian, C.5
Kim, K.6
Pajonk, F.7
-
17
-
-
33845904383
-
The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation
-
10.1093/jnci/djj495, 17179479
-
Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006, 98:1777-1785. 10.1093/jnci/djj495, 17179479.
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 1777-1785
-
-
Phillips, T.M.1
McBride, W.H.2
Pajonk, F.3
-
18
-
-
33846287519
-
WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells
-
10.1073/pnas.0606599104, 1766434, 17202265
-
Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, Rosen JM. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A 2007, 104:618-623. 10.1073/pnas.0606599104, 1766434, 17202265.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 618-623
-
-
Woodward, W.A.1
Chen, M.S.2
Behbod, F.3
Alfaro, M.P.4
Buchholz, T.A.5
Rosen, J.M.6
-
19
-
-
48949119473
-
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
-
10.1186/bcr1982, 2397524, 18366788
-
Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 2008, 10:R25. 10.1186/bcr1982, 2397524, 18366788.
-
(2008)
Breast Cancer Res
, vol.10
-
-
Fillmore, C.M.1
Kuperwasser, C.2
-
20
-
-
35848955428
-
ALDH1 Is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
-
10.1016/j.stem.2007.08.014, 2423808, 18371393
-
Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G. ALDH1 Is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567. 10.1016/j.stem.2007.08.014, 2423808, 18371393.
-
(2007)
Cell Stem Cell
, vol.1
, pp. 555-567
-
-
Ginestier, C.1
Hur, M.H.2
Charafe-Jauffret, E.3
Monville, F.4
Dutcher, J.5
Brown, M.6
Jacquemier, J.7
Viens, P.8
Kleer, C.G.9
Liu, S.10
Schott, A.11
Hayes, D.12
Birnbaum, D.13
Wicha, M.S.14
Dontu, G.15
-
21
-
-
62349116134
-
In vivo imaging, tracking, and targeting of cancer stem cells
-
10.1093/jnci/djn509, 2727141, 19244169
-
Vlashi E, Kim K, Lagadec C, Donna LD, McDonald JT, Eghbali M, Sayre JW, Stefani E, McBride W, Pajonk F. In vivo imaging, tracking, and targeting of cancer stem cells. J Natl Cancer Inst 2009, 101:350-359. 10.1093/jnci/djn509, 2727141, 19244169.
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 350-359
-
-
Vlashi, E.1
Kim, K.2
Lagadec, C.3
Donna, L.D.4
McDonald, J.T.5
Eghbali, M.6
Sayre, J.W.7
Stefani, E.8
McBride, W.9
Pajonk, F.10
-
22
-
-
33846512398
-
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
-
10.1073/pnas.0610117104, 1783424, 17210912
-
Prince ME. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl Acad. Sci. USA 2007, 104:973-978. 10.1073/pnas.0610117104, 1783424, 17210912.
-
(2007)
Proc. Natl Acad. Sci. USA
, vol.104
, pp. 973-978
-
-
Prince, M.E.1
-
23
-
-
79953042645
-
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
-
10.1038/nrc3023, 21390059
-
Zoller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?. Nat Rev Cancer 2011, 11:254-267. 10.1038/nrc3023, 21390059.
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 254-267
-
-
Zoller, M.1
-
24
-
-
84893797666
-
Targeting head and neck cancer stem cells to overcome resistance to photon and carbon ion radiation
-
10.1007/s12015-013-9467-y, 23955575
-
Bertrand G, Maalouf M, Boivin A, Battiston-Montagne P, Beuve M, Levy A, Jalade P, Fournier C, Ardail D, Magne N, Alphonse G, Rodriguez-Lafrasse C. Targeting head and neck cancer stem cells to overcome resistance to photon and carbon ion radiation. Stem Cell Reviews 2014, 10:114-126. 10.1007/s12015-013-9467-y, 23955575.
-
(2014)
Stem Cell Reviews
, vol.10
, pp. 114-126
-
-
Bertrand, G.1
Maalouf, M.2
Boivin, A.3
Battiston-Montagne, P.4
Beuve, M.5
Levy, A.6
Jalade, P.7
Fournier, C.8
Ardail, D.9
Magne, N.10
Alphonse, G.11
Rodriguez-Lafrasse, C.12
-
25
-
-
80053166769
-
Metabolic state of glioma stem cells and nontumorigenic cells
-
10.1073/pnas.1106704108, 3179043, 21900605
-
Vlashi E, Lagadec C, Vergnes L, Matsutani T, Masui K, Poulou M, Popescu R, Della Donna L, Evers P, Dekmezian C, Reue K, Christofk H, Mischel PS, Pajonk F. Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci U S A 2011, 108:16062-16067. 10.1073/pnas.1106704108, 3179043, 21900605.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 16062-16067
-
-
Vlashi, E.1
Lagadec, C.2
Vergnes, L.3
Matsutani, T.4
Masui, K.5
Poulou, M.6
Popescu, R.7
Della Donna, L.8
Evers, P.9
Dekmezian, C.10
Reue, K.11
Christofk, H.12
Mischel, P.S.13
Pajonk, F.14
-
26
-
-
0029847618
-
Two regions of homozygosity on chromosome 3p in squamous cell carcinoma of the head and neck: comparison with cytogenetic analysis
-
10.1002/(SICI)1097-0347(199611/12)18:6<529::AID-HED7>3.0.CO;2-4, 8902566
-
Buchhagen DL, Worsham MJ, Dyke DL, Carey TE. Two regions of homozygosity on chromosome 3p in squamous cell carcinoma of the head and neck: comparison with cytogenetic analysis. Head Neck 1996, 18:529-537. 10.1002/(SICI)1097-0347(199611/12)18:6<529::AID-HED7>3.0.CO;2-4, 8902566.
-
(1996)
Head Neck
, vol.18
, pp. 529-537
-
-
Buchhagen, D.L.1
Worsham, M.J.2
Dyke, D.L.3
Carey, T.E.4
-
27
-
-
0034305965
-
Phase III randomized trial of amifostine as a radioprotector in head and neck cancer
-
Brizel DM, Wasserman TH, Henke M, Strnad V, Rudat V, Monnier A, Eschwege F, Zhang J, Russell L, Oster W, Sauer R. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 2000, 18:3339-3345.
-
(2000)
J Clin Oncol
, vol.18
, pp. 3339-3345
-
-
Brizel, D.M.1
Wasserman, T.H.2
Henke, M.3
Strnad, V.4
Rudat, V.5
Monnier, A.6
Eschwege, F.7
Zhang, J.8
Russell, L.9
Oster, W.10
Sauer, R.11
-
28
-
-
20044370435
-
Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the german cancer society 95-06 prospective randomized trial
-
10.1200/JCO.2005.07.010, 15718308
-
Budach V, Stuschke M, Budach W, Baumann M, Geismar D, Grabenbauer G, Lammert I, Jahnke K, Stueben G, Herrmann T, Bamberg M, Wust P, Hinkelbein W, Wernecke KD. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the german cancer society 95-06 prospective randomized trial. J Clin Oncol 2005, 23:1125-1135. 10.1200/JCO.2005.07.010, 15718308.
-
(2005)
J Clin Oncol
, vol.23
, pp. 1125-1135
-
-
Budach, V.1
Stuschke, M.2
Budach, W.3
Baumann, M.4
Geismar, D.5
Grabenbauer, G.6
Lammert, I.7
Jahnke, K.8
Stueben, G.9
Herrmann, T.10
Bamberg, M.11
Wust, P.12
Hinkelbein, W.13
Wernecke, K.D.14
-
29
-
-
0142186283
-
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
-
Henke M, Laszig R, Rübe C, Schäfer U, Haase KD, Schilcher B, Mose S, Beer KT, Burger U, Dougherty C, Frommhold H. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. The Lancet 2003, 262:1255-1260.
-
(2003)
The Lancet
, vol.262
, pp. 1255-1260
-
-
Henke, M.1
Laszig, R.2
Rübe, C.3
Schäfer, U.4
Haase, K.D.5
Schilcher, B.6
Mose, S.7
Beer, K.T.8
Burger, U.9
Dougherty, C.10
Frommhold, H.11
-
30
-
-
10744229987
-
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy
-
10.1016/S0360-3016(03)01627-4, 14967419
-
Trotti A, Garden A, Warde P, Symonds P, Langer C, Redman R, Pajak TF, Fleming TR, Henke M, Bourhis J, Rosenthal DI, Junor E, Cmelak A, Sheehan F, Pulliam J, Devitt-Risse P, Fuchs H, Chambers M, OSullivan B, Ang KK. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Int J Radiat Oncol Biol Phys 2004, 58:674-681. 10.1016/S0360-3016(03)01627-4, 14967419.
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.58
, pp. 674-681
-
-
Trotti, A.1
Garden, A.2
Warde, P.3
Symonds, P.4
Langer, C.5
Redman, R.6
Pajak, T.F.7
Fleming, T.R.8
Henke, M.9
Bourhis, J.10
Rosenthal, D.I.11
Junor, E.12
Cmelak, A.13
Sheehan, F.14
Pulliam, J.15
Devitt-Risse, P.16
Fuchs, H.17
Chambers, M.18
OSullivan, B.19
Ang, K.K.20
more..
-
31
-
-
67650444760
-
ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
-
10.1016/j.jim.2009.06.008, 19567251
-
Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 2009, 347:70-78. 10.1016/j.jim.2009.06.008, 19567251.
-
(2009)
J Immunol Methods
, vol.347
, pp. 70-78
-
-
Hu, Y.1
Smyth, G.K.2
-
32
-
-
33750588816
-
Do erythropoietin receptors on cancer cells explain unexpected clinical findings?
-
10.1200/JCO.2006.06.2737, 17028293
-
Henke M, Mattern D, Pepe M, Bezay C, Weissenberger C, Werner M, Pajonk F. Do erythropoietin receptors on cancer cells explain unexpected clinical findings?. J Clin Oncol 2006, 24:4708-4713. 10.1200/JCO.2006.06.2737, 17028293.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4708-4713
-
-
Henke, M.1
Mattern, D.2
Pepe, M.3
Bezay, C.4
Weissenberger, C.5
Werner, M.6
Pajonk, F.7
-
33
-
-
78149423083
-
26S proteasome activity is down-regulated in lung cancer stem-like cells propagated in vitro
-
10.1371/journal.pone.0013298, 2952619, 20949018
-
Pan J, Zhang Q, Wang Y, You M. 26S proteasome activity is down-regulated in lung cancer stem-like cells propagated in vitro. PLoS One 2010, 5:e13298. 10.1371/journal.pone.0013298, 2952619, 20949018.
-
(2010)
PLoS One
, vol.5
-
-
Pan, J.1
Zhang, Q.2
Wang, Y.3
You, M.4
-
34
-
-
84862737662
-
Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents
-
e237
-
Adikrisna R, Tanaka S, Muramatsu S, Aihara A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Yamaoka S, Arii S. Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents. Gastroenterology 143(2012):234-245. e237.
-
Gastroenterology
, vol.143
, Issue.2012
, pp. 234-245
-
-
Adikrisna, R.1
Tanaka, S.2
Muramatsu, S.3
Aihara, A.4
Ban, D.5
Ochiai, T.6
Irie, T.7
Kudo, A.8
Nakamura, N.9
Yamaoka, S.10
Arii, S.11
-
35
-
-
84860335684
-
Radioresistance of prostate cancer cells with low proteasome activity
-
10.1002/pros.21489, 3396561, 21932424
-
Della Donna L, Lagadec C, Pajonk F. Radioresistance of prostate cancer cells with low proteasome activity. Prostate 2012, 72:868-874. 10.1002/pros.21489, 3396561, 21932424.
-
(2012)
Prostate
, vol.72
, pp. 868-874
-
-
Della Donna, L.1
Lagadec, C.2
Pajonk, F.3
-
36
-
-
84859056080
-
Oxygen levels do not determine radiation survival of breast cancer stem cells
-
10.1371/journal.pone.0034545, 3315542, 22479642
-
Lagadec C, Dekmezian C, Bauche L, Pajonk F. Oxygen levels do not determine radiation survival of breast cancer stem cells. PLoS One 2012, 7:e34545. 10.1371/journal.pone.0034545, 3315542, 22479642.
-
(2012)
PLoS One
, vol.7
-
-
Lagadec, C.1
Dekmezian, C.2
Bauche, L.3
Pajonk, F.4
-
37
-
-
79960607503
-
A pilot study to investigate the role of the 26S proteasome in radiotherapy resistance and loco-regional recurrence following breast conserving therapy for early breast cancer
-
10.1016/j.breast.2011.02.017, 21411324
-
Elfadl D, Hodgkinson VC, Long ED, Scaife L, Drew PJ, Lind MJ, Cawkwell L. A pilot study to investigate the role of the 26S proteasome in radiotherapy resistance and loco-regional recurrence following breast conserving therapy for early breast cancer. Breast 2011, 20:334-337. 10.1016/j.breast.2011.02.017, 21411324.
-
(2011)
Breast
, vol.20
, pp. 334-337
-
-
Elfadl, D.1
Hodgkinson, V.C.2
Long, E.D.3
Scaife, L.4
Drew, P.J.5
Lind, M.J.6
Cawkwell, L.7
-
38
-
-
84891804010
-
The RNA-binding protein Musashi-1 regulates proteasome subunit expression in breast cancer- and glioma-initiating cells
-
10.1002/stem.1537, 24022895
-
Lagadec C, Vlashi E, Frohnen P, Alhiyari Y, Chan M, Pajonk F. The RNA-binding protein Musashi-1 regulates proteasome subunit expression in breast cancer- and glioma-initiating cells. Stem cells 2014, 32:135-144. 10.1002/stem.1537, 24022895.
-
(2014)
Stem cells
, vol.32
, pp. 135-144
-
-
Lagadec, C.1
Vlashi, E.2
Frohnen, P.3
Alhiyari, Y.4
Chan, M.5
Pajonk, F.6
-
39
-
-
0028339821
-
The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities
-
10.1016/0360-3016(94)90269-0, 8195014
-
Bonner JA, Maihle NJ, Folven BR, Christianson TJ, Spain K. The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities. Int J Radiat Oncol Biol Phys 1994, 29:243-247. 10.1016/0360-3016(94)90269-0, 8195014.
-
(1994)
Int J Radiat Oncol Biol Phys
, vol.29
, pp. 243-247
-
-
Bonner, J.A.1
Maihle, N.J.2
Folven, B.R.3
Christianson, T.J.4
Spain, K.5
-
40
-
-
79955775758
-
Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases
-
10.1158/1535-7163.MCT-10-0643, 3073022, 21282353
-
Yang J, McEachern D, Li W, Davis MA, Li H, Morgan MA, Bai L, Sebolt JT, Sun H, Lawrence TS, Wang S, Sun Y. Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases. Mol Cancer Ther 2011, 10:658-669. 10.1158/1535-7163.MCT-10-0643, 3073022, 21282353.
-
(2011)
Mol Cancer Ther
, vol.10
, pp. 658-669
-
-
Yang, J.1
McEachern, D.2
Li, W.3
Davis, M.A.4
Li, H.5
Morgan, M.A.6
Bai, L.7
Sebolt, J.T.8
Sun, H.9
Lawrence, T.S.10
Wang, S.11
Sun, Y.12
|